Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Fuhrmann, V; Drolz, A; Trauner, M.
Extracorporeal artificial liver support systems in the management of intractable cholestatic pruritus.
Liver Int. 2011; 31 Suppl 3(9):31-33 Doi: 10.1111/j.1478-3231.2011.02584.x
PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Trauner Michael
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Pruritus can occur as a severe complication of cholestasis. Several hypotheses suggest an important role for the accumulation of bile acids, endogenous opioids and - mire recently - lysophosphatidic acid. Bile acid sequestrants are the first-line therapeutic agents. In refractory cases, a stepwise approach using rifampicin, oral opiate antagonists and the selective serotonin reuptake inhibitor sertraline should be tested. Recent case series reported effective relief of pruritus using extracorporal liver support systems and plasmapheresis.
Find related publications in this database (using NLM MeSH Indexing)
Cholestasis - complications
Cholestyramine Resin - therapeutic use
Humans -
Lysophospholipids - metabolism
Opioid Peptides - antagonists and inhibitors Opioid Peptides - metabolism
Plasmapheresis - methods
Pruritus - diagnosis Pruritus - drug therapy Pruritus - metabolism Pruritus - physiopathology Pruritus - therapy
Renal Dialysis - methods
Rifampin - therapeutic use
Sertraline - therapeutic use
Sorption Detoxification - methods
Ursodeoxycholic Acid - therapeutic use

© Med Uni GrazImprint